Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708513 · ClinicalTrials.gov registry record
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 98
- Enrollment target
NCT00708513: Completed study, sponsored by University of Louisville.
NCT00708513 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00708513 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2003-12 |
| Est. Completion | 2009-12 |
What the finished NCT00708513 record still lists
NCT00708513 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00708513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00708513 about?
NCT00708513 is a clinical study titled "Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.". The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.
What is the current status of trial NCT00708513?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2003-12. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00708513?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia